Author/Authors :
Khalaj, Hadi Rajaie Cardiovascular, Medical, and Research Center - Iran University of Medical Sciences, Tehran, IR Iran , Mozaffari, Kambiz Rajaie Cardiovascular, Medical, and Research Center - Iran University of Medical Sciences, Tehran, IR Iran , Givtag, Nozar Rajaie Cardiovascular, Medical, and Research Center - Iran University of Medical Sciences, Tehran, IR Iran , Zavvarei, Abbas Rajaie Cardiovascular, Medical, and Research Center - Iran University of Medical Sciences, Tehran, IR Iran , Mahdieh, Nejat Rajaie Cardiovascular, Medical, and Research Center - Iran University of Medical Sciences, Tehran, IR Iran
Abstract :
Background: Hepatitis C virus (HCV) infection is prevalent and potentially fatal in patients with
cirrhosis and hepatocellular carcinoma. The main routes of transmission are via sharing
syringes, blood products, and sexual contact. We sought to determine the incidence of HCV
infection among patients with cardiovascular diseases (CVDs) in an 18-month period.
Methods: During a period of 18 months, 39450 patients with CVDs underwent HCV Ab measurement
via the ELISA technique. Hbs Ag was also checked among HCV-positive cases in Rajaie
Cardiovascular, Medical, and Research Center in Tehran, Iran from 2015 to 2016.
Results: The patients were aged between 4 months and 97 years. In 72 out of the 39450 patients
(0.18%), HCV Ab was positive and 2 out of the 72 patients (2.7%) were also positive for HBs
Ag.
Conclusions: The prevalence of HCV infection in patients affected by CVDs in a single referral center
in Iran may be lower than that in other groups.
